DYRK2 and neoplasm: In tumor tissues, KLF4 showed elevated expression levels in cell lines enriched with CSCs (194) and maintained self-renewal of CSCs by targeting dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) and inducing telomerase expression.